Shandong Weigao Medical Polymer Price to Free Cash Flow Ratio 2012-2024 | SHWGF

Shandong Weigao Medical Polymer price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as

Shandong Weigao Medical Polymer Price to Free Cash Flow Ratio 2012-2024 | SHWGF

Shandong Weigao Medical Polymer price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$205.7B
Stryker (SYK)$140B
Boston Scientific (BSX)$123.1B
Medtronic (MDT)$115.5B
EssilorLuxottica (ESLOY)$107.3B
Lonza Group Ag (LZAGY)$45.5B
Haleon (HLN)$44B
GE HealthCare Technologies (GEHC)$39.7B
ResMed (RMD)$35.9B
Terumo (TRUMY)$28.3B
Koninklijke Philips (PHG)$24.9B
Zimmer Biomet Holdings (ZBH)$21.4B
Baxter (BAX)$18.3B
Insulet (PODD)$16.5B
Smith & Nephew SNATS (SNN)$11B
Bio-Rad Laboratories (BIO)$10.3B
BellRing Brands (BRBR)$8.6B
Demant (WILYY)$8.4B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.2B
TG Therapeutics (TGTX)$4.2B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.7B
Envista Holdings (NVST)$3.6B
Perrigo (PRGO)$3.6B
Neogen (NEOG)$3.1B
GN Store Nord (GNNDY)$3B
QuidelOrtho (QDEL)$2.6B
Agios Pharmaceuticals (AGIO)$2.6B
Green Thumb Industries (GTBIF)$2.2B